Detalhe da pesquisa
1.
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
Lancet Oncol
; 24(3): 297-306, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739879
2.
Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
J Pathol
; 258(1): 58-68, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681273
3.
Laparoscopic-assisted liver transplantation: A realistic perspective.
Am J Transplant
; 22(12): 3069-3077, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704274
4.
Immunophenotypic and molecular characterization of pancreatic neuroendocrine tumors producing serotonin.
Mod Pathol
; 35(11): 1713-1722, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35739266
5.
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors.
Neuroendocrinology
; 112(6): 537-546, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348346
6.
The long-term outcomes of laparoscopic versus open pancreatoduodenectomy for ampullary carcinoma showed similar survival: a case-matched comparative study.
Surg Endosc
; 36(7): 4732-4740, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724575
7.
Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinoma.
Pancreatology
; 2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34090806
8.
Contribution of Immune-Mediated Paraneoplastic Syndromes to Neurological Manifestations of Neuroendocrine Tumours: A Retrospective Study.
Neuroendocrinology
; 111(1-2): 123-128, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040952
9.
Prognostic impact of bone metastases detected by 18F-DOPA PET in patients with metastatic midgut neuroendocrine tumors.
Eur Radiol
; 31(6): 4166-4174, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33247341
10.
Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
Eur Radiol
; 31(11): 8671-8681, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33977308
11.
O-positive blood type is associated with prolonged recurrence-free survival following curative resection of pancreatic neuroendocrine tumors.
Pancreatology
; 20(8): 1718-1722, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33032924
12.
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor.
Neuroendocrinology
; 110(1-2): 83-91, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31071715
13.
The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors.
Neuroendocrinology
; 110(11-12): 967-976, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791037
14.
Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine Tumours.
Neuroendocrinology
; 110(5): 404-412, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31430756
15.
Correction to: Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging.
Eur Radiol
; 30(11): 6387, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32500190
16.
How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort.
Ann Surg Oncol
; 26(1): 109-117, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30362063
17.
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses.
Neuroendocrinology
; 108(4): 343-353, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30759445
18.
18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation.
Neuroendocrinology
; 106(3): 274-282, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28803235
19.
Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE).
Neuroendocrinology
; 106(1): 38-46, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28152531
20.
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms.
Neuroendocrinology
; 107(1): 24-31, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29518779